| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PB | 666 | 99.0% | -0.87 | 365 | 99.2% |
| CentralBrain-unspecified | 7 | 1.0% | -1.22 | 3 | 0.8% |
| upstream partner | # | NT | conns P6-8P9 | % In | CV |
|---|---|---|---|---|---|
| Delta7 (L) | 21 | Glu | 114 | 35.1% | 0.7 |
| EPG (L) | 12 | ACh | 84 | 25.9% | 0.6 |
| Delta7 (R) | 7 | Glu | 43.5 | 13.4% | 0.7 |
| P6-8P9 (L) | 2 | Glu | 35 | 10.8% | 0.2 |
| IbSpsP (L) | 8 | ACh | 18 | 5.5% | 0.6 |
| PFNv (L) | 6 | ACh | 16.5 | 5.1% | 0.7 |
| OA-AL2i1 (L) | 1 | unc | 3.5 | 1.1% | 0.0 |
| EPGt (L) | 2 | ACh | 3.5 | 1.1% | 0.1 |
| LPsP (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LPsP (R) | 1 | ACh | 1.5 | 0.5% | 0.0 |
| PFGs (L) | 2 | unc | 1 | 0.3% | 0.0 |
| SpsP (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| PFNp_e (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| PFNm_b (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| downstream partner | # | NT | conns P6-8P9 | % Out | CV |
|---|---|---|---|---|---|
| EPGt (L) | 2 | ACh | 103.5 | 15.1% | 0.2 |
| PFNa (L) | 7 | ACh | 101.5 | 14.8% | 0.9 |
| IbSpsP (L) | 3 | ACh | 78 | 11.4% | 0.5 |
| Delta7 (R) | 12 | Glu | 51 | 7.5% | 1.2 |
| PFNm_b (L) | 4 | ACh | 49 | 7.2% | 0.6 |
| LPsP (L) | 1 | ACh | 48.5 | 7.1% | 0.0 |
| PFNv (L) | 2 | ACh | 36 | 5.3% | 0.7 |
| P6-8P9 (L) | 2 | Glu | 35 | 5.1% | 0.2 |
| PFNp_b (L) | 14 | ACh | 33.5 | 4.9% | 0.8 |
| PFNp_c (L) | 5 | ACh | 30.5 | 4.5% | 0.7 |
| PEG (L) | 2 | ACh | 25 | 3.7% | 1.0 |
| LPsP (R) | 1 | ACh | 24.5 | 3.6% | 0.0 |
| PFNm_a (L) | 2 | ACh | 24.5 | 3.6% | 0.9 |
| Delta7 (L) | 11 | Glu | 13 | 1.9% | 0.5 |
| PFNp_e (L) | 3 | ACh | 7.5 | 1.1% | 0.6 |
| PEN_b(PEN2) (L) | 2 | ACh | 5 | 0.7% | 0.4 |
| PFGs (L) | 2 | unc | 5 | 0.7% | 0.0 |
| SpsP (L) | 2 | Glu | 5 | 0.7% | 0.2 |
| PFNp_a (L) | 5 | ACh | 4 | 0.6% | 0.5 |
| PFNd (L) | 2 | ACh | 2.5 | 0.4% | 0.6 |
| EPG (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PEN_a(PEN1) (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| PFNp_d (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
